Market Overview

According to fortune business insights, The global cartilage repair market size was valued at USD 1.58 billion in 2025. The market is projected to grow from USD 1.71 billion in 2026 to USD 3.32 billion by 2034, exhibiting a CAGR of 8.7% during the forecast period. North America dominated the global cartilage repair market with a market share of 44.93% in 2025.

The analysis shows that market growth is driven by increasing sports-related injuries, a rising prevalence of osteoarthritis, and advancements in regenerative biologics. Leading companies are focused on continual product development, research, and geographic expansion to maintain their market dominance.

Major Players Profiled in the Market Report:

• Vericel Corporation (U.S.)
• Zimmer Biomet Holdings, Inc. (U.S.)
• Stryker Corporation (U.S.)
• Arthrex, Inc. (U.S.)
• Smith & Nephew plc (U.K.)
• Johnson & Johnson (U.S.)
• Anika Therapeutics, Inc. (U.S.)
• Geistlich Pharma AG (Switzerland)
• MTF Biologics (U.S.)
• AlloSource (U.S.)

Segments

Affordability and Availability to Drive Non-Cell-Based Approaches Segment Growth

Based on treatment, the market is classified into cell-based and non-cell-based approaches. The non-cell-based approaches segment held the highest market share in 2025, as these methods are generally simpler, more affordable, and do not require special laboratories.

Properties of Collagen-based Materials to Accelerate Segment Growth

By material, the market is categorized into collagen-based materials, hyaluronic acid-based materials, hydrogel, and others. The collagen-based materials segment captured the largest share as these materials mimic the body’s natural extracellular matrix, encouraging cell growth and tissue formation.

Substantial Prevalence of Knee Injuries to Accelerate Knee Cartilage Repair Segment Growth